SCHEMBL13598259

SCHEMBL13598259

Cc1cc(C)c2c(=O)cc(-c3c(C)c(C)c(C)c(C)c3C)oc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A2 P19784 1/20 0.51
▸ CSNK2B P67870 1/20 0.51
▸ CSNK2A1 P68400 1/20 0.51
▸ ADORA3 P0DMS8 2/20 0.48
▸ MAPT P10636 5/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ TP53 P04637 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ KMT2A Q03164 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ PON1 P27169 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ ABCB1 P08183 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ AR P10275 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28925280 0.78 ADORA3 (0.50) CSNK2A2CSNK2BCSNK2A1ADORA3MAPT
SCHEMBL28568538 0.78 CYP3A4 (0.72) CSNK2A2CSNK2BCSNK2A1ADORA3MAPT
SCHEMBL13479744 0.76 CSNK2A2 (0.64) CSNK2A2CSNK2BCSNK2A1ADORA3MAPT
SCHEMBL20664412 0.73 ADORA3 (0.76) CSNK2A2CSNK2BCSNK2A1ADORA3MAPT
SCHEMBL28914421 0.72 GABRP (0.57) CSNK2A2CSNK2BCSNK2A1ADORA3MAPT
SCHEMBL28568624 0.71 AHR (0.52) CSNK2A2CSNK2BCSNK2A1MAPTSMN1; SMN2
SCHEMBL24046768 0.70 CSNK2A2 (0.51) CSNK2A2CSNK2BCSNK2A1ADORA3MAPT
SCHEMBL12325499 0.70 KMT2A (0.50) CSNK2A2CSNK2BCSNK2A1MAPTSMN1; SMN2
SCHEMBL28588026 0.69 CYP3A4 (0.62) CSNK2A2CSNK2BCSNK2A1ADORA3MAPT
SCHEMBL28576015 0.69 CSNK2A2 (0.53) CSNK2A2CSNK2BCSNK2A1ADORA3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090324656-A1 COSMETIC PREPARATIONS WITH AN ADDITIVE FROM THE BAOBAB TREE ENGELS PETER 2009-12-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090324656-A1 COSMETIC PREPARATIONS WITH AN ADDITIVE FROM THE BAOBAB TREE CUTA, BROX, MANBA CSNK2A2 3473/4885CSNK2B 2118/4885CSNK2A1 3663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback